Albatira, Baby Boy T.
HRN: 21-26-46 Sex: MalePatient Encounter
AMS Audit List
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/23/2022
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
05/23/2022
05/30/2022
IV
36mg
Q8h
NEC
Waiting Final Action